111 related articles for article (PubMed ID: 2431005)
1. Measuring S100 protein and neurone specific enolase in melanocytic tumours using video image analysis.
Williams RA; Rode J; Dhillon AP; Jarvis LR; Skinner JM; Jamal O
J Clin Pathol; 1986 Oct; 39(10):1096-8. PubMed ID: 2431005
[TBL] [Abstract][Full Text] [Related]
2. S100 protein, neurone specific enolase, and nuclear DNA content in Spitz naevus.
Rode J; Williams RA; Jarvis LR; Dhillon AP; Jamal O
J Pathol; 1990 May; 161(1):41-5. PubMed ID: 2370597
[TBL] [Abstract][Full Text] [Related]
3. Neurone specific enolase and S100 protein as possible prognostic indicators in melanoma.
Rode J; Dhillon AP
Histopathology; 1984 Nov; 8(6):1041-52. PubMed ID: 6526386
[TBL] [Abstract][Full Text] [Related]
4. Patterns of staining for neurone specific enolase in benign and malignant melanocytic lesions of the skin.
Dhillon AP; Rode J
Diagn Histopathol; 1982; 5(3):169-74. PubMed ID: 6183082
[TBL] [Abstract][Full Text] [Related]
5. The value of S-100 immunostaining as a diagnostic tool in human malignant melanomas. A comparative study using S-100 and neuron-specific enolase antibodies.
Springall DR; Gu J; Cocchia D; Michetti F; Levene A; Levene MM; Marangos PJ; Bloom SR; Polak JM
Virchows Arch A Pathol Anat Histopathol; 1983; 400(3):331-43. PubMed ID: 6412442
[TBL] [Abstract][Full Text] [Related]
6. Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions.
Mackie RM; Campbell I; Turbitt ML
J Clin Pathol; 1984 Apr; 37(4):367-72. PubMed ID: 6200506
[TBL] [Abstract][Full Text] [Related]
7. Cadherin expression in melanocytic naevi and malignant melanomas.
Cowley GP; Smith ME
J Pathol; 1996 Jun; 179(2):183-7. PubMed ID: 8758211
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
Petersson S; Shubbar E; Enerbäck L; Enerbäck C
Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263
[TBL] [Abstract][Full Text] [Related]
9. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.
Orosz Z
Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696
[TBL] [Abstract][Full Text] [Related]
10. Expression of endoglin in human melanocytic lesions.
Dawn G; MacKie RM
Clin Exp Dermatol; 2002 Mar; 27(2):153-6. PubMed ID: 11952710
[TBL] [Abstract][Full Text] [Related]
11. Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases.
Anstey A; Cerio R; Ramnarain N; Orchard G; Smith N; Jones EW
Am J Dermatopathol; 1994 Feb; 16(1):14-22. PubMed ID: 7512798
[TBL] [Abstract][Full Text] [Related]
12. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
Pluot M; Joundi A; Grosshans E
Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
[TBL] [Abstract][Full Text] [Related]
14. Discrimination between benign and malignant melanocytic skin lesions by multivariate analysis, quantitative S-100 immunohistochemistry, nuclear morphometry and DNA cytometry.
Williams RA; Rode J; Baak JP; Charlton IG
Anal Quant Cytol Histol; 1999 Aug; 21(4):353-7. PubMed ID: 10560514
[TBL] [Abstract][Full Text] [Related]
15. S100A6 protein expression is different in Spitz nevi and melanomas.
Ribé A; McNutt NS
Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
[TBL] [Abstract][Full Text] [Related]
16. WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases.
Furusato E; Hidayat AA; Man YG; Auerbach A; Furusato B; Rushing EJ
Arch Ophthalmol; 2009 Aug; 127(8):964-9. PubMed ID: 19667332
[TBL] [Abstract][Full Text] [Related]
17. PGP 9.5, a new marker for human neuroendocrine tumours.
Rode J; Dhillon AP; Doran JF; Jackson P; Thompson RJ
Histopathology; 1985 Feb; 9(2):147-58. PubMed ID: 2580771
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of the S100A1, S100B, CD44 and Bcl-2 antigens and the rate of cell proliferation assessed by Ki-67 antibody in benign and malignant melanocytic tumours.
Sviatoha V; Tani E; Kleina R; Sperga M; Skoog L
Melanoma Res; 2010 Apr; 20(2):118-25. PubMed ID: 20042890
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of S-100 protein and neuron specific enolase (NSE) in melanocytes and the related tumors.
Hachisuka H; Sakamoto F; Nomura H; Mori O; Sasai Y
Acta Histochem; 1986; 80(2):215-23. PubMed ID: 3101377
[TBL] [Abstract][Full Text] [Related]
20. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
